Endocrine Today highlighted a study led by Anne Peters, MD, showing that patients with Type 2 diabetes may experience glycemic benefits with automated insulin delivery

Post: Endocrine Today highlighted a study led by Anne Peters, MD, showing that patients with Type 2 diabetes may experience glycemic benefits with automated insulin delivery

On March 8, Endocrine Today highlighted a study led by Anne Peters, MD, endocrinologist with Keck Medicine and professor of medicine (clinical scholar), showing that patients with Type 2 diabetes may experience glycemic benefits with automated insulin delivery. Click link to read more: Endocrine Today

Share:

More Posts